Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis
Xue Kong(Shanghai Ocean University), Ken H. Young(Duke Medical Center), Weina Chen(Army Medical University), Govind Bhagat(Columbia University Irving Medical Center), Benjamin M. Parsons(Gundersen Health System), Hui Yan(Zigong First People's Hospital), Xiaoxian Zhao(Atrium Health Wake Forest Baptist), Eric D. Hsi(Mayo Clinic), Zijun Y. Xu‐Monette(Duke University), Leon Bernal‐Mizrachi(Emory University), Shuna Yao(Zhengzhou University), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Dehong Wu(Jiangsu University), Michael Møller(Hospital South West Jutland), April Chiu(Mayo Clinic), Zenggang Pan(University of Colorado Anschutz Medical Campus), Youli Zu(Methodist Hospital), Wayne Tam(Cornell University), Qingyan Au(NeoGenomics (United States)), Alexander M. Xu(Cedars-Sinai Medical Center), Zhenming Xu(Central South University), Akil Merchant(University of Southern California), Fenghuang Zhan(Winthrop Rockefeller Foundation), Santiago Montes‐Moreno(Universidad de Cantabria), Shanxiang Zhang(Indiana University School of Medicine), Harry Nunns(NeoGenomics (United States)), Yong Li(Baylor College of Medicine), Karolyn Au(University of Alberta), Karen Dybkær(Aalborg University Hospital)
Cited by 2
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718